4//SEC Filing
Seshadri Vishwas 4
Accession 0001493152-25-016543
CIK 0000318306other
Filed
Sep 30, 8:00 PM ET
Accepted
Oct 1, 4:30 PM ET
Size
7.8 KB
Accession
0001493152-25-016543
Insider Transaction Report
Form 4
Seshadri Vishwas
DirectorChief Executive Officer
Transactions
- Sale
Common Stock
2025-09-29$5.39/sh−19,274$103,954→ 1,215,067 total - Sale
Common Stock
2025-09-30$5.24/sh−25,000$130,930→ 1,190,067 total
Footnotes (4)
- [F1]The sale reported in this Form 4 was to cover tax obligations associated with the vesting of restricted stock awards.
- [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.35 to $5.46 inclusive. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.
- [F3]The reported sale of 25,000 shares occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 18, 2024.
- [F4]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.20 to $5.2725 inclusive. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.
Documents
Issuer
ABEONA THERAPEUTICS INC.
CIK 0000318306
Entity typeother
Related Parties
1- filerCIK 0001865131
Filing Metadata
- Form type
- 4
- Filed
- Sep 30, 8:00 PM ET
- Accepted
- Oct 1, 4:30 PM ET
- Size
- 7.8 KB